Intuitive saw a 16% year-over-year rise in worldwide procedures in the second quarter. Procedures with its da Vinci robotic ...

The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.

(This story has been republished to remove an image, with no changes to text) July 16 (Reuters) - Intuitive Surgical on Thursday maintained its 2026 forecast for worldwide growth in procedures ...

Intuitive Surgical is a leader in surgical robotics, and the stock has a history of deep drawdowns.

Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics ...

You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue ...

The only real miss was the 2026 procedure growth guide, but the installed base is still expanding (da Vinci +12%, Ion +21%), ...

Intuitive Surgical shares fell as much as 13% in after-market trading as growth in use of its da Vinci surgical robots slowed ...

Intuitive Surgical's stock has fallen sharply in 2026, but that is more a function of investor sentiment than of the company.

Intuitive, a leader in robotic-assisted surgery (RAS), announced two studies showing that RAS improves access to high-quality care and enhances patient outcomes, particularly in areas with limited ...

July 17 (Reuters) - Intuitive Surgical shares fell more than 12% before the bell on Friday after it maintained its global ...

Shares of the Maker of Robotic Surgical Tools Led S&P 500 Decliners on Friday ...